IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
| Revenue (Most Recent Fiscal Year) | $3.66B |
| Net Income (Most Recent Fiscal Year) | $845.04M |
| PE Ratio (Current Year Earnings Estimate) | 44.33 |
| PE Ratio (Trailing 12 Months) | 49.08 |
| PEG Ratio (Long Term Growth Estimate) | 3.81 |
| Price to Sales Ratio (Trailing 12 Months) | 11.21 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 27.65 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 42.76 |
| Pre-Tax Margin (Trailing 12 Months) | 28.99% |
| Net Margin (Trailing 12 Months) | 23.08% |
| Return on Equity (Trailing 12 Months) | 71.66% |
| Return on Assets (Trailing 12 Months) | 28.11% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.57 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.17 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.42 |
| Inventory Turnover (Trailing 12 Months) | 3.77 |
| Book Value per Share (Most Recent Fiscal Quarter) | $17.88 |
| Earnings per Share (Most Recent Fiscal Quarter) | $2.32 |
| Earnings per Share (Most Recent Fiscal Year) | $10.06 |
| Diluted Earnings per Share (Trailing 12 Months) | $10.07 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 83.05M |
| Free Float | 81.30M |
| Market Capitalization | $41.05B |
| Average Volume (Last 20 Days) | 0.41M |
| Beta (Past 60 Months) | 1.26 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.11% |
| Percentage Held By Institutions (Latest 13F Reports) | 87.84% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |